These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 24335130)
1. Intraperitoneal compared with intravenous meropenem for peritoneal dialysis-related peritonitis. Vlaar PJ; van Hulst M; Benne CA; Janssen WM Perit Dial Int; 2013; 33(6):708-9. PubMed ID: 24335130 [No Abstract] [Full Text] [Related]
2. Intraperitoneal Meropenem for Polymicrobial Peritoneal Dialysis-Related Peritonitis. de Fijter CW; Jakulj L; Amiri F; Zandvliet A; Franssen E Perit Dial Int; 2016 9-10; 36(5):572-3. PubMed ID: 27659932 [TBL] [Abstract][Full Text] [Related]
3. Improved Outcome of Enteric Peritonitis in Peritoneal Dialysis Patients Aged 50 Years and Older with Temporary Discontinuation of Peritoneal Dialysis and Intravenous Meropenem. Abrahams AC; Rüger W; Ter Wee PM; van Ittersum FJ; Boer WH Perit Dial Int; 2017; 37(3):298-306. PubMed ID: 28096441 [TBL] [Abstract][Full Text] [Related]
4. Daptomycin in peritoneal dialysis, intraperitoneal or intravenous. Pérez Melón C; Borrajo Prol M; Iglesias E; Ferreiro B; Camba Caride M Nefrologia; 2016; 36(4):461-2. PubMed ID: 26680497 [No Abstract] [Full Text] [Related]
5. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis. Wiesholzer M; Pichler P; Reznicek G; Wimmer M; Kussmann M; Balcke P; Burgmann H; Zeitlinger M; Poeppl W Antimicrob Agents Chemother; 2016 May; 60(5):2790-7. PubMed ID: 26902765 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Peritoneal Dialysis May Result in Vascular Changes Within the Peritoneal Cavity, Leading to Reduced Efficacy of Intravenous Antibiotics in Treatment of Bacterial Peritonitis. Attique HB; Naik S; Haroon A; Trivedi RD Am J Med; 2017 Oct; 130(10):e449-e450. PubMed ID: 28601541 [No Abstract] [Full Text] [Related]
16. Efficacy and safety of meropenem plus tobramycin followed by meropenem plus vancomycin for treating peritonitis in patients on continuous ambulatory peritoneal dialysis. Kobayashi K; Nakamoto H; Okada S; Hoshitani K; Uchida K; Arima H; Shoda J; Takane Y; Ikeda N; Sugahara S; Okada H; Suzuki H Adv Perit Dial; 2006; 22():65-8. PubMed ID: 16983942 [TBL] [Abstract][Full Text] [Related]
17. Intravenous antibiotics with adjunctive lavage in refractory peritonitis. Wong SS; Yu AW; Lau WY; Chan PK; Cheng YL Perit Dial Int; 2014; 34(7):805-8. PubMed ID: 25520488 [No Abstract] [Full Text] [Related]
18. Intraperitoneal meropenem administration: a possible alternative to the intravenous route. Van Ende C; Tintillier M; Cuvelier C; Migali G; Pochet JM Perit Dial Int; 2010; 30(2):250-1. PubMed ID: 20200373 [No Abstract] [Full Text] [Related]
19. Successful treatment of Aeromonas hydrophila peritoneal dialysis-associated peritonitis using intermittent intraperitoneal gentamicin. Eisele G; Bailie GR Clin Nephrol; 1995 Dec; 44(6):402. PubMed ID: 8719554 [No Abstract] [Full Text] [Related]
20. Prostatic penetration of meropenem after intravenous administration in patients undergoing transurethral resection of the prostate. Yamada Y; Ikawa K; Nakamura K; Mitsui K; Narushima M; Hibi H; Ikeda K; Morikawa N; Honda N J Chemother; 2011 Jun; 23(3):179-80. PubMed ID: 21742590 [No Abstract] [Full Text] [Related] [Next] [New Search]